Amylyx Pharmaceuticals
AMLX
AMLX
154 hedge funds and large institutions have $1.18B invested in Amylyx Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 66 increasing their positions, 43 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
4.19% more ownership
Funds ownership: 77% → 81.19% (+4.2%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
22% less capital invested
Capital invested by funds: $1.51B → $1.18B (-$331M)
Holders
154
Holding in Top 10
5
Calls
$46.9M
Puts
$37.2M
Top Buyers
| 1 | +$24.2M | |
| 2 | +$18.3M | |
| 3 | +$18.1M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.2M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$14.2M |
Top Sellers
| 1 | -$25M | |
| 2 | -$23.9M | |
| 3 | -$20.1M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$18M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$13.9M |